SCHEMBL7039680

SCHEMBL7039680

COC(=O)c1cc(O)ccc1NC(=O)c1ccc(Cl)cc1Cl

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 4/20 0.59
PPARA Q07869 2/20 0.59
ALDH1A1 P00352 2/20 0.56
RAB9A P51151 3/20 0.54
NPC1 O15118 2/20 0.54
SMN1; SMN2 Q16637 2/20 0.54
TP53 P04637 3/20 0.53
HDAC1 Q13547 2/20 0.53
HDAC8 Q9BY41 2/20 0.53
HDAC6 Q9UBN7 2/20 0.53
MAPT P10636 2/20 0.49
FLT1 P17948 1/20 0.49
FLT4 P35916 1/20 0.49
KDR P35968 1/20 0.49
LMNA P02545 1/20 0.49
CA12 O43570 2/20 0.49
CA1 P00915 2/20 0.49
CA2 P00918 2/20 0.49
CA7 P43166 2/20 0.49
CA9 Q16790 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7036191 0.88 PPARG (0.57) PPARGPPARAALDH1A1RAB9ANPC1
SCHEMBL7033047 0.85 RAB9A (0.58) PPARGALDH1A1RAB9ASMN1; SMN2HDAC1
SCHEMBL7034504 0.85 PPARG (0.54) PPARGPPARAALDH1A1RAB9ANPC1
SCHEMBL7040693 0.84 PPARG (0.60) PPARGPPARAALDH1A1TP53HDAC8
SCHEMBL7037291 0.83 PPARG (0.52) PPARGPPARAALDH1A1RAB9ANPC1
SCHEMBL7038586 0.82 PPARG (0.61) PPARGPPARAALDH1A1NPC1SMN1; SMN2
SCHEMBL7036241 0.81 PPARG (0.80) PPARGPPARASMN1; SMN2TP53MAPT
SCHEMBL2889149 0.81 TP53 (0.54) PPARGPPARAALDH1A1RAB9ANPC1
SCHEMBL7036249 0.80 PPARG (0.75) PPARGPPARAALDH1A1RAB9ANPC1
SCHEMBL7035471 0.80 PPARG (0.49) PPARGPPARAALDH1A1RAB9ANPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20030082631-A1 Compounds modulating PPAR-gamma BIOVITRUM AB (SE) 2003-05-01 US disclosed
US-20030073862-A1 Compounds BIOVITRUM AB (SE) 2003-04-17 US disclosed
WO-2003005025-A1 METHODS FOR IDENTIFYING COMPOUNDS MODULATING THE ACTIVITY OF PPAR-GAMMA BIOVITRUM AB (SE) 2003-01-16 WO disclosed
WO-2003004458-A1 NEW COMPOUNDS BIOVITRUM AB (SE) 2003-01-16 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030082631-A1 Compounds modulating PPAR-gamma PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885ALDH1A1 1495/4885
US-20030073862-A1 Compounds PPARG, PPARA, PPARD PPARG 1/4885PPARA 2/4885ALDH1A1 383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.